AI Trading NASDAQ Thu, 08 Dec
If you invested in NVCR from 2015-10-13 to 2022-09-15 with our AI-driven strategy, you would have earned a 1358.83% return. The average trade returned 50.33% after 58.0 days in the long position, with a total of 27.0 positions taken during the period.
NVCR refers to NovoCure, a publicly-traded biotechnology company. NovoCure specializes in the development of cancer treatments. The company has developed a proprietary technology called Tumor Treating Fields (TTF) that utilizes electric fields to inhibit tumor growth. NovoCure is currently trading on the NASDAQ exchange under the ticker symbol NVCR.
The company has a market capitalization of $15.3 billion and has seen its share price increase by over 500% in the last five years. The stock is currently trading around $90 per share, up from its 52-week low of $20.90.
Analysts have a generally positive outlook on the stock, citing the company’s strong fundamentals and potential for long-term growth. The company has recently reported strong financial results and has several promising clinical trials in the pipeline that could lead to further growth.
Overall, NovoCure is a promising stock in the biotechnology sector and could be an attractive investment for long-term growth investors.
AI Trading NASDAQ Thu, 08 Dec buys
|Date||Symbol||Prediction||Model Accuracy||Price Target|
AI Trading NASDAQ Thu, 08 Dec sells
Back-testing and model summaries
|Symbol||From Date||To Date||Model Accuracy||Acc Profit/Loss||Avg Profit/Loss||Avg Days Invested||Total Positions|
Thanks for subscribing and happy investing!
The Third Perspective Team